ONCOCYTE CORP's ticker is OCX and the CUSIP is 68235C107. A total of 57 filers reported holding ONCOCYTE CORP in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $9,000 | -30.8% | 5,847 | 0.0% | 0.00% | – |
| Q4 2021 | $13,000 | -38.1% | 5,847 | 0.0% | 0.00% | – |
| Q3 2021 | $21,000 | -47.5% | 5,847 | -15.2% | 0.00% | – |
| Q2 2021 | $40,000 | -2.4% | 6,896 | -12.5% | 0.00% | – |
| Q1 2021 | $41,000 | +127.8% | 7,877 | +4.4% | 0.00% | – |
| Q4 2020 | $18,000 | +80.0% | 7,545 | 0.0% | 0.00% | – |
| Q3 2020 | $10,000 | -28.6% | 7,545 | +6.4% | 0.00% | – |
| Q2 2020 | $14,000 | +100.0% | 7,094 | +143.0% | 0.00% | – |
| Q1 2020 | $7,000 | -22.2% | 2,919 | -32.7% | 0.00% | – |
| Q4 2019 | $9,000 | +28.6% | 4,339 | +21.3% | 0.00% | – |
| Q3 2019 | $7,000 | -22.2% | 3,576 | 0.0% | 0.00% | – |
| Q2 2019 | $9,000 | +800.0% | 3,576 | +831.2% | 0.00% | – |
| Q1 2018 | $1,000 | -50.0% | 384 | 0.0% | 0.00% | – |
| Q4 2017 | $2,000 | -87.5% | 384 | -81.8% | 0.00% | – |
| Q3 2017 | $16,000 | +45.5% | 2,115 | 0.0% | 0.00% | – |
| Q2 2017 | $11,000 | – | 2,115 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BROADWOOD CAPITAL INC | 14,716,204 | $20,456,000 | 1.61% |
| PURA VIDA INVESTMENTS, LLC | 6,022,534 | $8,371,000 | 0.43% |
| P.A.W. CAPITAL CORP | 199,700 | $278,000 | 0.30% |
| Penbrook Management LLC | 229,425 | $319,000 | 0.28% |
| PERKINS CAPITAL MANAGEMENT INC | 39,725 | $55,000 | 0.05% |
| GSA CAPITAL PARTNERS LLP | 201,047 | $279,000 | 0.05% |
| Private Wealth Partners, LLC | 150,000 | $209,000 | 0.02% |
| Phoenix Holdings Ltd. | 317,138 | $426,000 | 0.02% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 255,300 | $355,000 | 0.01% |
| ETF MANAGERS GROUP, LLC | 157,933 | $226,000 | 0.01% |